BFA
CELGZ

Beaumont Financial Advisors’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Beaumont Financial Advisors’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,000
Closed -$9K – 303
2019
Q3 		$9K Hold
15,000
– – ﹤0.01% 272
2019
Q2 		$9K Hold
15,000
– – ﹤0.01% 247
2019
Q1 		$17K Hold
15,000
– – ﹤0.01% 231
2018
Q4 		$7K Hold
15,000
– – ﹤0.01% 196
2018
Q3 		$24K Hold
15,000
– – ﹤0.01% 230
2018
Q2 		$5K Hold
15,000
– – ﹤0.01% 206
2018
Q1 		$4K Buy
+15,000
New +$9.83K ﹤0.01% 206

Beaumont Financial Advisors's CELGZ Position: Q4 2019 in Review

Beaumont Financial Advisors sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 15,000 shares — an estimated $9K sold.

Beaumont Financial Advisors first reported a position in CELGZ in Q1 2018 and held it in 7 quarters. The position peaked at $24K in Q3 2018. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

  • Beaumont Financial Advisors reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Beaumont Financial Advisors sold 15,000 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $9K.
  • Beaumont Financial Advisors first reported a position in Celgene Corporation Contingent Value Rights in Q1 2018 and held it in 7 quarters.
  • Beaumont Financial Advisors's Celgene Corporation Contingent Value Rights position peaked at $24K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Beaumont Financial Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.